HHS will let pharmacies make popular peptides not approved by the FDA

NPR | By Sydney Lupkin

Published October 29, 2026 at 4:45 AM EDT

The Department of Health and Human Services released a policy Wednesday that would allow compounding pharmacies to make six peptides that haven't been approved by the FDA.

Sydney Lupkin

Sydney Lupkin is the pharmaceuticals correspondent for NPR, where she has reported on accelerated drug approvals whose confirmatory trials were overdue, Operation Warp Speed contract accountability, and the ripple effects of obesity drug shortages.

See stories by Sydney Lupkin

Support nonprofit, fact-based public service journalism

WEKU depends on support from those who view and listen to our content. There's no paywall here. Please support WEKU with your donation.

Contribute now

Related Content

NPR News

How AI drones are influencing the course of the Ukraine war

Joanna Kakissis

Artificial intelligence is making drones faster and more capable. Russia and Ukraine both use AI-powered drones, and Ukrainian President Volodymyr Zelenskyy has warned that AI could lead decisions on the battlefield as soon as next year.
The Commonwealth

US 23 has given an Eastern Kentucky city an economic lifeline, report says

Curtis Tate

A recent report from the Appalachian Regional Commission says the highway is now critical to the area's success.
NPR News

State ballots let voters decide on abortion, taxes, transgender restrictions

Jahd Khalil

Missouri voters could ban abortion - after they just removed a ban two years ago. California voters could tax billionaires 5% of their wealth.
NPR News

Business as a liberal art? Some high schools say yes

Stephan Bisaha

Learning about money is becoming a growing part of the high school curriculum.
Watch

NPR News

Ahead of midterms, Missourians defend transgender healthcare

Bram Sable-Smith

The campaign to defend access to transgender healthcare for young people in Missouri is taking an unhurried approach to talking with voters about the proposed ban.